Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cerebroside + carnosine
- Development stage
- Phase 3
- Modality
- Small Molecules, Peptides
- Administration
- Injection
01
Overview
Cerebroside + carnosine (Chinese name: 脑苷肌肽) is a combination drug formulation used primarily in China as a neurotrophic agent. It contains two main components: - **Cerebrosides** are glycosphingolipids found in animal nerve tissue, believed to support neuronal repair and regeneration. - **Carnosine** is a naturally occurring dipeptide (beta-alanyl-L-histidine) with antioxidant, anti-glycation, and metal-chelating properties. Carnosine is concentrated in muscle and brain tissues and has been studied for its neuroprotective effects[1][2][5]. This combination is typically administered by injection for the treatment of neurological conditions such as stroke recovery, peripheral facial paralysis (Bell’s palsy), traumatic brain injury, or other central nervous system disorders where neuroprotection or neural repair is desired[4]. The mechanism of action involves antioxidation (carnosine), membrane stabilization, promotion of neuronal survival and repair (cerebrosides), and possible modulation of neurotransmitter systems.
- Brand names
- 脑苷肌肽
- Other names
- brain glycoside-carnosine脑苷肌肽注射液
02
Targets
Aβ (Amyloid-beta peptides and aggregates)MMP2 (Matrix metalloproteinase-2)
Beyond the preview
Go deeper on cerebroside + carnosine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cerebroside + carnosine.